Cargando…

Osteosarcoma: a review of current and future therapeutic approaches

Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globall...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xin, Wu, Qirui, Gong, Xiuqing, Liu, Jinfeng, Ma, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923306/
https://www.ncbi.nlm.nih.gov/pubmed/33653371
http://dx.doi.org/10.1186/s12938-021-00860-0
_version_ 1783658882023817216
author Zhao, Xin
Wu, Qirui
Gong, Xiuqing
Liu, Jinfeng
Ma, Yujie
author_facet Zhao, Xin
Wu, Qirui
Gong, Xiuqing
Liu, Jinfeng
Ma, Yujie
author_sort Zhao, Xin
collection PubMed
description Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options.
format Online
Article
Text
id pubmed-7923306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79233062021-03-02 Osteosarcoma: a review of current and future therapeutic approaches Zhao, Xin Wu, Qirui Gong, Xiuqing Liu, Jinfeng Ma, Yujie Biomed Eng Online Review Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options. BioMed Central 2021-03-02 /pmc/articles/PMC7923306/ /pubmed/33653371 http://dx.doi.org/10.1186/s12938-021-00860-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Zhao, Xin
Wu, Qirui
Gong, Xiuqing
Liu, Jinfeng
Ma, Yujie
Osteosarcoma: a review of current and future therapeutic approaches
title Osteosarcoma: a review of current and future therapeutic approaches
title_full Osteosarcoma: a review of current and future therapeutic approaches
title_fullStr Osteosarcoma: a review of current and future therapeutic approaches
title_full_unstemmed Osteosarcoma: a review of current and future therapeutic approaches
title_short Osteosarcoma: a review of current and future therapeutic approaches
title_sort osteosarcoma: a review of current and future therapeutic approaches
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923306/
https://www.ncbi.nlm.nih.gov/pubmed/33653371
http://dx.doi.org/10.1186/s12938-021-00860-0
work_keys_str_mv AT zhaoxin osteosarcomaareviewofcurrentandfuturetherapeuticapproaches
AT wuqirui osteosarcomaareviewofcurrentandfuturetherapeuticapproaches
AT gongxiuqing osteosarcomaareviewofcurrentandfuturetherapeuticapproaches
AT liujinfeng osteosarcomaareviewofcurrentandfuturetherapeuticapproaches
AT mayujie osteosarcomaareviewofcurrentandfuturetherapeuticapproaches